Patritumab deruxtecan shows meaningful clinical activity in heavily pretreated patients with metastatic breast cancer and active brain metastases, a phase 2 trial reports.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/patritumab-deruxtecan-clinically-active-against-metastatic-2025a1000uo5?src=rss
Author :
Publish date : 2025-11-10 12:00:00
Copyright for syndicated content belongs to the linked Source.
